| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:1413.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (S.E.V., W.S., P.J.K., D.W.J.D.), Erasmus Medical Center, Rotterdam; and the Department of Neurology (A.A., L.J.K.), University Medical Center Utrecht, The Netherlands.
Correspondence to S.E. Vermeer, MD, PhD, Erasmus Medical Center, Department of Neurology, PO Box 2040, 3000 CA Rotterdam, The Netherlands. E-mail s.vermeer{at}erasmusmc.nl
Background and Purpose Impaired glucose tolerance, an intermediate metabolic state between normal glucose and diabetes characterized by nonfasting glucose levels between 7.8 to 11.0 mmol/L, is associated with an increased stroke risk in patients with coronary heart disease. Whether impaired glucose tolerance increases the risk of stroke in patients with transient ischemic attack (TIA) or minor ischemic stroke is unknown.
Methods In total, 3127 patients with a TIA or minor ischemic stroke participated in the Dutch TIA Trial, testing 2 different doses of aspirin and atenolol versus placebo. We estimated the risk of stroke and the risk of myocardial infarction or cardiac death in relation to baseline nonfasting glucose levels (mean 6.0, SD 2.2 mmol/L) with Cox proportional hazards regression analysis, adjusted for cardiovascular risk factors.
Results During 2.6 years follow-up, 272 patients (9%) experienced a stroke and 200 (6%) a myocardial infarction or cardiac death. We found a J-shaped relationship between baseline nonfasting glucose levels and stroke risk. Stroke risk was nearly doubled in patients with impaired glucose tolerance (glucose 7.8 to 11.0 mmol/L) compared with those with normal glucose levels (hazard ratio [HR] 1.8, 95% CI, 1.1 to 3.0) and nearly tripled in diabetic patients (glucose
11.1 mmol/L; HR 2.8, 95% CI, 1.9 to 4.1). Patients with low glucose levels (<4.6 mmol/L) had a 50% increased stroke risk (HR 1.5, 95% CI, 1.0 to 2.2) compared with those with normal glucose levels. There was no association between glucose levels and risk of myocardial infarction or cardiac death.
Conclusion Impaired glucose tolerance is an independent risk factor for future stroke in nondiabetic patients with TIA or minor ischemic stroke.
Key Words: glucose glucose intolerance risk transient ischemic attack
This article has been cited by other articles:
![]() |
J. R. Romero, J. Morris, and A. Pikula Review: Stroke prevention: modifying risk factors Therapeutic Advances in Cardiovascular Disease, August 1, 2008; 2(4): 287 - 303. [Abstract] [PDF] |
||||
![]() |
C. Nielson and R. M. Fleming Blood Glucose and Cerebrovascular Disease in Nondiabetic Patients Angiology, November 1, 2007; 58(5): 625 - 629. [Abstract] [PDF] |
||||
![]() |
F. M. Ivey, A. S. Ryan, C. E. Hafer-Macko, A. P. Goldberg, and R. F. Macko Treadmill Aerobic Training Improves Glucose Tolerance and Indices of Insulin Sensitivity in Disabled Stroke Survivors: A Preliminary Report Stroke, October 1, 2007; 38(10): 2752 - 2758. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tsuda Hyperinsulinemia and Membrane Microviscosity of Erythrocytes as Risk Factors for Stroke in Patients With Impaired Glucose Tolerance Stroke, November 1, 2006; 37(11): 2657 - 2657. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |